Lenz Therapeutics, Inc. · NASDAQ:LENZ
BlackRock, Inc.'s stake in Lenz Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc.'s stake in Lenz Therapeutics, Inc. fell to 4.90%, 1,537,723 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 1,537,723
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.90% | 1,537,723 |
Source
Related
- Lenz Therapeutics, Inc.
- BlackRock, Inc.
- Lenz Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G · BlackRock, Inc. · Oct 17, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 21, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Schedule 13G · Millennium Management LLC · Jun 26, 2026
- Schedule 13G · Squarepoint Ops LLC · Apr 8, 2026
- Schedule 13G/A · Ridgeback Capital Investments L.P. · Feb 17, 2026